Summarized by Masters of Longevity from PR Newswire.
AI in clinical trials: a market outlook piece that previews how artificial intelligence tools are being applied across recruitment, analysis and drug development workflows, and what adoption challenges and opportunities readers should expect.
Key Takeaways
- AI use across clinical trials is expanding to speed patient recruitment, trial design, and large-scale data analysis efficiently.
- Widespread adoption faces barriers including data privacy concerns, regulatory compliance, and the need for high-quality clinical data.
- Pharmaceutical companies, CROs, hospitals, and research institutes are increasingly integrating machine learning, NLP, and deep learning to support drug discovery and personalized medicine.
